5AM Partners VI, LLC - Jan 11, 2022 Form 4 Insider Report for CinCor Pharma, Inc. (CINC)

Role: 10%+ Owner
Signature: 5AM Partners VI, LLC, By /s/ Kush Parmar, Managing Member
Stock symbol: CINC
Transactions as of: Jan 11, 2022
Transactions value $: $7,520,000
Form type: 4
Date filed: 1/13/2022, 03:45 PM
Previous filing: Jan 6, 2022
Next filing: Aug 17, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CINC	Common Stock	Conversion of derivative security		+3.68M			3.68M	Jan 11, 2022	By 5AM Ventures VI, L.P.	F1, F2
transaction	CINC	Common Stock	Conversion of derivative security		+184K			184K	Jan 11, 2022	By 5AM Opportunities I, L.P.	F1, F3
transaction	CINC	Common Stock	Purchase	$2.52M	+158K	+4.28%	$16.00	3.84M	Jan 11, 2022	By 5AM Ventures VI, L.P.	F2
transaction	CINC	Common Stock	Purchase	$5M	+313K	+170%	$16.00	496K	Jan 11, 2022	By 5AM Opportunities I, L.P.	F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CINC	Series A Preferred Stock	Conversion of derivative security	$0	-10M	-100%	$0.00^*	0	Jan 11, 2022	Common Stock	2.94M		By 5AM Ventures VI, L.P.	F1, F2
transaction	CINC	Series B Preferred Stock	Conversion of derivative security	$0	-2.53M	-100%	$0.00^*	0	Jan 11, 2022	Common Stock	743K		By 5AM Ventures VI, L.P.	F1, F2
transaction	CINC	Series B Preferred Stock	Conversion of derivative security	$0	-625K	-100%	$0.00^*	0	Jan 11, 2022	Common Stock	184K		By 5AM Opportunities I, L.P.	F1, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each share of Series A Preferred Stock and Series B Preferred Stock automatically converted into shares of Common Stock immediately prior to the closing of the Issuer's initial public offering (the "IPO") for no additional consideration, on a 3.4:1 basis, and had no expiration date.
F2	The shares are directly held by 5AM Ventures VI, L.P. ("Ventures VI"). 5AM Partners VI, LLC ("Partners VI") is the sole general partner of Ventures VI. Dr. Kush Parmar and Andrew J. Schwab are the managing members of Partners VI and may be deemed to have shared voting and investment power over the shares beneficially owned by Ventures VI. Each of Partners VI, Dr. Parmar, and Mr. Schwab disclaims beneficial ownership of such shares except to the extent of its or his pecuniary interest therein.
F3	Shares are held by 5AM Opportunities I, L.P. ("Opportunities"). 5AM Opportunities I (GP), LLC ("Opportunities GP") is the sole general partner of Opportunities. Andrew J. Schwab and Dr. Kush Parmar are the managing members of Opportunities GP and may be deemed to have shared voting and investment power over the shares beneficially owned by Opportunities. Each of Opportunities GP, Mr. Schwab and Dr. Parmar disclaims beneficial ownership of such shares except to the extent of its or his pecuniary interest therein.